# Raw Agent Run Log

- `run_id`: RUN_20260527_223821_09_openclaw_deepseekv4pro_isolated
- `case_id`: C004
- `variant_id`: level3
- `level`: level3
- `agent_name`: openclaw
- `agent_id`: benchmark_isolated
- `model`: deepseek-v4-pro
- `model_provider`: deepseek
- `openclaw_build_or_version`: 2026.5.5
- `channel`: cli
- `temperature`: not_supported
- `top_p`: not_supported
- `max_tokens`: not_supported
- `seed`: not_supported
- `tools_enabled`: locally_isolated_remote_tool_enabled
- `closed_book`: false
- `timestamp`: 2026-05-27T22:38:21+0800
- `input_file`: benchmark/cases/C004_paid_search_effectiveness/agent_task_level3.md
- `system_prompt_summary`: workspace=/Users/jiangcanxiang/OpenClawBenchmarkIsolated; thinking=high; actual_tool_use=none; agent=benchmark_isolated
- `contamination_status`: unknown
- `contamination_reason`: pending manual content review; actual tool use=none
- `status`: success

## Raw Agent Output

# Research Design: Causal Effect of Paid Search Availability on Downstream Purchases

---

## 1. Executive Summary

This design proposes a market-level difference-in-differences (DiD) framework leveraging planned variation in paid search availability across comparable market areas. The research exploits repeated pre-period and intervention-period sales observations to estimate the causal effect of removing (or activating) paid search at the market level on downstream purchases. Because individual click-and-conversion metrics confound intent with persuasion, the design shifts the unit of analysis to the market, where treatment assignment is controlled by the firm or platform rather than by user behavior. Heterogeneity across user-history segments (prior familiarity, recency, frequency) is examined through segment-stratified outcome analysis and, where data permit, a within-market segment-by-treatment interaction design. The design cannot fully disentangle all causal mechanisms — particularly the informational versus route-substitution distinction — but provides the strongest defensible empirical strategy given the available data and institutional constraints.

---

## 2. Research Question

Does making paid search available in a market cause incremental downstream purchases, and do these effects differ between users with low versus high prior familiarity or activity with the firm?

---

## 3. Target Estimand

The **average treatment effect on the treated markets (ATT)** at the market level:

**τ = E[Y_it(1) − Y_it(0) | D_i = 1, t ∈ post]**

where Y_it is the downstream sales outcome in market i at time t, D_i = 1 indicates paid search is available in market i during the intervention period, and the counterfactual Y_it(0) is the sales outcome that would have occurred had paid search been unavailable.

**Heterogeneous treatment effects** are defined as:

**τ^segment = E[Y_it^s(1) − Y_it^s(0) | D_i = 1, t ∈ post]**

where s indexes user-history segments (e.g., low-familiarity, inactive, active).

If the parallel-trends assumption is not credible, the strongest defensible estimand is a **conditional difference-in-differences** estimate with explicit bounding of selection bias, or, failing that, a **descriptive pre-post comparison** across treatment arms supplemented with trend diagnostics.

---

## 4. Treatment/Exposure and Main Outcomes

| Variable | Definition | Level | Timing |
|---|---|---|---|
| **Treatment (D_it)** | Indicator: paid search is available for the focal traffic class in market i during time t | Market × time | Intervention window |
| **Treatment intensity** (if observed) | Duration or spend intensity of paid search availability | Market | Intervention window |
| **Primary outcome (Y_it)** | Downstream purchases, sales, or order counts recorded after search-driven or all-channel acquisition | Market × time | Pre-period and intervention period |
| **Secondary outcomes** | Segment-specific sales (Y_it^s); new-to-firm or less-active-user purchase counts; revenue | Market × time × segment | Pre-period and intervention period |

---

## 5. Data Structure Summary

The data form a **balanced or near-balanced panel** of market-by-time observations:

- **Cross-section**: M comparable market areas, where some receive paid search availability and others do not during the intervention window.
- **Time dimension**: T_pre pre-period observations and T_post intervention-period observations per market, with continuous sales recording.
- **Segment dimension**: Each market-time cell can be split into user-history segments defined by pre-period familiarity, recency, or frequency.
- **Assignment level**: Market (or market-time cell if treatment varies within market over time).
- **Outcome measurement level**: Market × time, with optional market × time × segment disaggregation.
- **Recommended inference level**: Clustered standard errors at the market level (or matched-market-pair level if pairing was part of treatment assignment).

The panel structure is a critical strength: it allows within-market pre-trend inspection, time-fixed-effect absorption, and market-level fixed-effect estimation.

---

## 6. Relevant Causal Mechanisms

The packet identifies four mechanisms that the design must distinguish:

1. **Informational/discovery effect (demand creation)**: Paid search exposes users with low prior familiarity or long absence to the firm, generating purchases that would not have occurred otherwise. This is the mechanism that makes paid search genuinely incremental.

2. **Route-substitution effect (channel shifting)**: Already-informed users who would have arrived through unpaid (organic) search or direct navigation instead click the paid link. Purchases are real but not incremental to the firm — only the channel changes.

3. **Intent-selection effect (measurement confound)**: Users who click paid search links have higher baseline purchase intent. Naively attributing their subsequent purchases to the ad overstates causal effect because these users' intent drove both the click and the purchase.

4. **Composition effect (aggregation masking heterogeneity)**: Near-zero average effects may hide positive effects for low-familiarity users and negative (substitution-dominated) effects for active users.

---

## 7. Main Identification Challenge

The central challenge is that **individual-level ad exposure, clicks, and attributed conversions are endogenous to user intent**. Users self-select into clicking (or not clicking) paid search results, and those who click differ systematically in purchase propensity from those who do not. Individual-level click-to-conversion analysis therefore conflates the causal effect of paid search with baseline differences in user intent.

A secondary challenge is that **market-level treatment variation addresses individual-level selection but creates its own threats**: (a) treated and untreated markets may differ in pre-existing demand trends, (b) users in treated markets may substitute to unpaid channels or direct navigation, and (c) spillovers across markets or channels may bias market-level estimates.

---

## 8. Whether Credible Causal Identification Is Possible

**Conditional yes, with important caveats.** Credible causal identification of the market-level effect of paid search availability is possible under a difference-in-differences framework if:

- Pre-period outcome trends are parallel across treated and untreated markets;
- Treatment assignment (which markets received paid search) is not systematically correlated with time-varying demand shocks during the intervention window;
- Spillovers are negligible or can be bounded;
- The composition of user segments within markets does not change endogenously in response to treatment.

For **mechanism-specific claims** (demand creation vs. route substitution), causal identification is substantially weaker. The available data allow segment-level heterogeneity analysis that is *suggestive* of mechanisms but cannot *causally isolate* the informational effect from the route-substitution effect without individual-level channel-substitution data.

For **segment-specific causal effects**, identification depends on whether segment composition is measured entirely from pre-period data (avoiding post-treatment conditioning bias) and whether segments are sufficiently populated within each market to support within-market estimation.

If pre-trends are not parallel and no defensible correction is available, the analysis reduces to a **descriptive comparison** of outcome changes across treatment arms, with explicit acknowledgment that differences may reflect selection rather than causation.

---

## 9. Proposed Empirical Design

### Primary Design: Market-Level Difference-in-Differences

**Step 1 — Validate comparability.**
Using pre-period data only, examine whether treated and untreated markets follow parallel outcome trends. Plot raw market-level sales over time by treatment status. Estimate pre-trend differentials formally:

Y_it = α_i + λ_t + Σ_{k≠-1} δ_k · (D_i × 1[t − t* = k]) + ε_it

where t* is the intervention start, and the δ_k for k < 0 test for differential pre-trends. Absence of significant pre-trend δ_k supports the parallel-trends assumption.

**Step 2 — Estimate the average treatment effect.**
Using the full panel (pre and post), estimate:

Y_it = α_i + λ_t + τ · (D_i × Post_t) + ε_it

where α_i are market fixed effects, λ_t are time fixed effects, D_i indicates paid search availability, and Post_t indicates the intervention period. τ is the ATT.

**Step 3 — Cluster inference at the market level.**
Standard errors clustered at the market level to reflect the level of treatment assignment.

**Step 4 — Examine dynamic treatment effects.**
Extend to an event-study specification:

Y_it = α_i + λ_t + Σ_k τ_k · (D_i × 1[t − t* = k]) + ε_it

This reveals whether effects emerge gradually (consistent with discovery) or appear immediately and stabilize (potentially consistent with route substitution or intent capture).

### Heterogeneity Analysis: User-History Segments

**Approach A — Stratified DiD (preferred if segment × market × time cells are well-populated):**

For each pre-defined segment s (based on pre-period familiarity, recency, or frequency):

Y_it^s = α_i^s + λ_t^s + τ^s · (D_i × Post_t) + ε_it^s

Compare τ^s across segments. Positive τ for low-familiarity/inactive segments and near-zero τ for active segments would be consistent with the discovery mechanism. Equal τ across segments would be consistent with route substitution or uniform effects.

**Approach B — Triple-difference (DDD) (if within-market segment data support it):**

Y_its = α_is + λ_ts + γ_it + τ_DDD · (D_i × Post_t × LowFamiliarity_s) + ε_its

where LowFamiliarity_s is a pre-period segment indicator, α_is are market-by-segment fixed effects, λ_ts are time-by-segment fixed effects, and γ_it are market-by-time fixed effects (absorbing the aggregate DiD). τ_DDD identifies whether the treatment effect differs for low-familiarity users *within the same market and time period*, over and above the aggregate effect.

**Key design choice**: All segment assignments must be defined using **pre-period data only** to avoid conditioning on post-treatment variables (which would bias estimates).

### Addressing Specific Threats Through Design

| Mechanism to distinguish | Design element |
|---|---|
| Discovery vs. route substitution | Segment heterogeneity + event-study dynamics; discovery effects should concentrate among low-familiarity users and may grow over time |
| Intent-selection confound | Market-level treatment avoids individual click-driven selection; intent is absorbed into market fixed effects and pre-trends |
| Composition masking | Explicit segment-level estimation; test whether aggregate τ ≈ weighted average of segment τ^s |
| Spillover | Untreated-market trends serve as a diagnostic; persistent below-trend sales in untreated markets may indicate negative spillovers from treatment markets |

---

## 10. Why the Design Is Valid

The DiD design addresses the fundamental problem — individual-level selection into ad exposure — by moving identification to the market level. Because paid search availability is controlled at the market level by the firm or platform, the treatment assignment is exogenous to *individual* user behavior. Any remaining selection concerns operate at the market level, where they are testable through pre-trend analysis.

The design's validity rests on:

1. **Treatment is assigned, not chosen by users.** Individual-level endogeneity (the intent-selection problem) is eliminated by design.
2. **Pre-trends are testable.** The event-study specification allows formal testing of parallel trends.
3. **Market fixed effects absorb time-invariant differences.** Permanent market characteristics (size, demographics, baseline demand) are differenced out.
4. **Time fixed effects absorb common shocks.** Seasonality and common demand shifts are controlled.
5. **Segment analysis uses pre-period stratification.** Avoiding post-treatment conditioning bias.

If parallel trends fail, the design is not valid as a causal strategy, and the strongest defensible analysis is a descriptive comparison with explicit caveats.

---

## 11. Required Assumptions

### Identification Assumptions

1. **Parallel trends (counterfactual)**: In the absence of paid search availability, treated markets would have followed the same sales trajectory as untreated markets. This is the core identifying assumption; it is not directly testable but is supported by pre-trend diagnostics.

2. **No anticipatory effects**: Markets and users did not change behavior before the intervention in anticipation of paid search availability changes. Testable by examining pre-period outcomes immediately before treatment.

3. **Stable unit treatment value assumption (SUTVA) at the market level**: Treatment in one market does not affect outcomes in other markets. This includes:
   - No cross-market user substitution (users in untreated markets searching from treated-market locations).
   - No strategic firm reallocation of other marketing resources across treatment arms.

4. **No time-varying confounding**: No shocks during the intervention window differentially affect treated and untreated markets through channels other than paid search.

5. **Pre-period segment stability**: User-history segment definitions based on pre-period data remain meaningful and do not mechanically change in composition due to the treatment itself.

### Estimation Assumptions

6. **Correctly specified functional form**: Additive treatment effects and linear conditional means.
7. **No post-treatment conditioning**: Segment assignment and covariate definitions use only pre-period data.
8. **Sufficient within-market segment observations**: Segment-level DiD requires enough observations per market-segment-time cell.

---

## 12. Statistical Model

### Primary Specification

For market i in time period t:

**Y_it = α_i + λ_t + β · D_i · Post_t + γ · X_it + ε_it**

where:
- Y_it: Downstream sales (purchases, orders, or revenue)
- α_i: Market fixed effects
- λ_t: Time fixed effects
- D_i: Market-level paid search availability indicator (=1 if market i ever received treatment during the intervention window; if treatment varies within-market over time, this becomes D_it)
- Post_t: Indicator for intervention period (=1 if t ≥ t*)
- X_it: Time-varying covariates (if available: local demand indicators, competitor activity; note: post-treatment covariates must be excluded)
- ε_it: Error term, clustered at market level

**Parameter of interest**: β estimates the ATT of paid search availability on downstream purchases.

### Event-Study Specification

**Y_it = α_i + λ_t + Σ_{k = k_min}^{k_max} β_k · 1[t − t* = k] · D_i + γ · X_it + ε_it**

where k indexes time relative to intervention start, with k = −1 as the reference period. β_k for k ≥ 0 trace the dynamic treatment effect.

### Segment-Stratified Specification

For each segment s:

**Y_it^s = α_i^s + λ_t^s + β^s · D_i · Post_t + γ · X_it + ε_it^s**

where inference on β^s uses market-clustered standard errors within each segment regression.

### Triple-Difference Specification (if data support)

**Y_its = α_is + λ_ts + γ_it + δ · D_i · Post_t · LowFamiliarity_s + ε_its**

where γ_it are market-by-time fixed effects that absorb the level-2 DiD terms. δ identifies differential treatment effect for low-familiarity segments.

---

## 13. Robustness, Placebo, and Falsification Checks

### Pre-Trend Diagnostics

1. **Visual inspection**: Raw and residualized outcome plots by treatment status over the full time series.
2. **Joint F-test** on pre-period event-study coefficients (β_k for k < 0). Failure to reject supports parallel trends.
3. **Linear pre-trend test**: Regress pre-period outcomes on treatment indicator × time trend; the interaction should be insignificant.

### Placebo Tests

4. **In-time placebo**: Falsely assign treatment to a pre-period date and estimate the DiD on pre-period data only. A null effect supports the absence of differential pre-trends.
5. **In-space placebo**: If multiple untreated markets exist, randomly reassign treatment status among untreated markets and estimate the DiD. The distribution of placebo estimates should center on zero.
6. **Leave-one-out**: Iteratively drop one treated market and re-estimate to check sensitivity to any single market.

### Robustness

7. **Alternative outcome measures**: Repeat analysis using revenue, order counts, and new-customer acquisitions (if available).
8. **Alternative inference methods**: 
   - Wild cluster bootstrap for small number of markets.
   - Synthetic control method (SCM) as a complement, constructing a synthetic counterfactual for each treated market from the pool of untreated markets.
9. **Varying bandwidth**: Estimate using different pre-period windows to check sensitivity to the choice of baseline period.
10. **Treatment intensity**: Replace binary treatment with continuous intensity measures (duration of availability, spend level) if observed.

### Mechanism Diagnostics

11. **Segment effect patterns**: Test whether β^low_familiarity > β^high_familiarity. This pattern is necessary (though not sufficient) for a discovery mechanism.
12. **Event-study shape by segment**: Examine whether low-familiarity segment effects grow over time (consistent with gradual discovery) while active-segment effects are immediate and flat (consistent with route substitution).
13. **Composition check**: Verify that the aggregate β is approximately the weighted average of segment-specific β^s, testing for aggregation bias.

---

## 14. Heterogeneity Analysis

### Pre-Specified Segments (based on pre-period data only)

| Segment | Definition | Mechanism hypothesis |
|---|---|---|
| **New / unfamiliar** | Zero or near-zero prior purchases; no account or browsing history | Discovery effect dominant; β expected positive |
| **Lapsed / infrequent** | Prior purchases but long recency (> 6 months) or low frequency | Mixed discovery and reactivation; β expected positive but smaller |
| **Active / frequent** | Recent and frequent prior purchases | Route substitution dominant; β expected near zero or negative |
| **Organic-only users** | Prior channel use is exclusively organic/direct (never paid) | Pure discovery if converted; may be the most informative segment |

### Estimation Approach

1. Estimate segment-stratified DiD for each segment.
2. Test H₀: β^new = β^active via the triple-difference specification.
3. Report segment-specific estimates with market-clustered confidence intervals.
4. If segment cell sizes are small, pool lapsed and infrequent segments into a "low-activity" composite.

### Important Caveats

- Segment-specific effects are identified under the assumption that segment composition within markets is stable over time.
- If treatment induces market entry by new users (a genuine discovery effect), the *composition* of segments may shift endogenously. The pre-period segment definitions avoid mechanical bias, but compositional change is itself a potential channel of the treatment effect and should be reported descriptively.

---

## 15. Measurement, Compliance, Missingness, Spillover, and Implementation Limits

### Measurement Limits

- **Aggregate sales may obscure channel sourcing**: Total market sales cannot distinguish a purchase that was "caused" by paid search discovery from one that would have occurred via organic search in a treated market. This is the fundamental limitation of market-level analysis for mechanism isolation.
- **Segment classification quality**: If user-history data are incomplete (e.g., cookie deletion, cross-device usage), segment assignment contains measurement error that attenuates heterogeneity estimates toward zero.
- **Cross-channel tracking**: If users switch devices or clear identifiers between search and purchase, purchases may not be linked to the correct user history, introducing further measurement error.

### Compliance and Take-Up

- **Market-level availability ≠ individual exposure**: Even in treated markets, not all users see paid search ads (query-dependent), and seeing an ad does not guarantee clicking. The estimand is an **intent-to-treat (ITT)** effect at the market level — the effect of *making paid search available*, not the effect of *being exposed to paid search*.
- **Treatment intensity variation**: If spend levels or keyword coverage differ across treated markets, the binary DiD estimates a weighted average that may mask intensity heterogeneity. If intensity data are available, a dose-response analysis can be performed.

### Missingness

- **Aggregate sales are typically well-measured**: Minimal concern for the primary outcome.
- **Segment data may be incomplete**: Users with no pre-period history cannot be classified (this is itself informative — they belong in the low-familiarity segment). Report the proportion of unclassified purchases transparently.

### Spillover and Interference

- **Cross-market spillover**: Users near market boundaries may search in one market and purchase in another. If market definitions follow administrative or media-market boundaries, this risk is reduced but not eliminated.
- **Cross-channel spillover (within market)**: In treated markets, some users who would have used organic search may instead use paid search. This is the route-substitution mechanism — it is part of the treatment effect being estimated, not a bias per se. The market-level DiD correctly captures the *net* effect (new purchases minus displaced organic purchases).
- **Diagnostic**: If untreated markets show a decline in sales during the intervention (relative to their own pre-trend), this may indicate users shifting from untreated to treated markets. However, this pattern could also reflect common shocks, so interpretation is cautious.

### Implementation Limits

- **Small number of markets**: With few treated and untreated markets, cluster-robust inference may be unreliable. The wild cluster bootstrap or SCM is recommended as a complement.
- **Single treatment wave**: If all treated markets receive treatment simultaneously, time fixed effects and treatment effects are not separately identified without a control group. This is the standard DiD setup and is fine as long as untreated markets exist.
- **Repeated exposure dynamics**: Users in treated markets face repeated search opportunities. The DiD captures the cumulative effect over the intervention window but cannot separately identify the effect of a single exposure versus repeated exposure.

---

## 16. Failure Modes and Alternative Explanations

### Failure Mode 1: Non-Parallel Pre-Trends

**What it looks like**: Treated markets were already on a different growth trajectory before the intervention.

**Why it matters**: Violates the core identifying assumption. Any post-period difference may reflect pre-existing divergence rather than treatment.

**Diagnostic**: Pre-trend event-study coefficients are significantly different from zero.

**Response**: If divergence is linear and stable, include market-specific linear trends. If non-linear, the design cannot support causal claims; report descriptive comparisons only. Synthetic control methods may help if a suitable donor pool exists.

### Failure Mode 2: Differential Time-Varying Shocks

**What it looks like**: A demand shock (local economic event, competitor entry/exit, platform algorithm change) affects treated and untreated markets differently during the intervention window.

**Why it matters**: Confounds treatment with the shock.

**Diagnostic**: Difficult to test directly. Examine whether results are robust to excluding markets with known shocks. Check whether effects appear in outcomes that should not be affected by paid search (e.g., purchases of products not advertised).

**Response**: Cannot be ruled out from available data. Acknowledge as a limitation.

### Failure Mode 3: Strategic Firm Behavior

**What it looks like**: The firm reallocates other marketing resources (email campaigns, display ads, promotions) across treatment arms in response to paid search availability.

**Why it matters**: The estimated effect confounds paid search with correlated changes in other marketing.

**Diagnostic**: If data on other marketing activities are available, test for differential changes across treatment arms.

**Response**: Without data on other marketing channels, this remains an unobserved confound. Acknowledge.

### Failure Mode 4: Negative Spillover Masks True Effect

**What it looks like**: Paid search in treated markets cannibalizes sales from untreated markets (e.g., users traveling between markets).

**Why it matters**: The DiD comparison of treated vs. untreated markets estimates the *differential* effect, not the absolute effect of paid search. If untreated markets lose sales to treated markets, the DiD overstates the net effect.

**Diagnostic**: Examine whether untreated market sales decline during the intervention (relative to pre-trend). If decline is present and correlates with proximity to treated markets, spillover is plausible.

**Response**: If spillover is suspected, report the DiD as a lower bound on the effect of making paid search unavailable everywhere. Consider spatial models if distance data are available.

### Failure Mode 5: Segment Composition Changes Endogenously

**What it looks like**: Paid search attracts genuinely new users, changing the composition of user segments in treated markets.

**Why it matters**: This is partly the mechanism of interest (discovery) but complicates segment-level analysis. If segment shares change, the aggregate β reflects both within-segment effects and compositional shifts.

**Diagnostic**: Compare segment shares pre- and post-intervention across treatment arms.

**Response**: Report both within-segment effects and compositional shifts. Decompose the aggregate effect into within-segment and between-segment (compositional) components using a Oaxaca-Blinder-style decomposition if appropriate.

### Alternative Explanations for Observed Effects

- **Positive aggregate β**: Could reflect demand creation, reduced substitution to competitors, or market-expansion effects. Could also reflect a favorable demand shock coincident with treatment.
- **Zero aggregate β**: Could reflect no causal effect. Could also reflect demand creation offset by equal route substitution (positive for unfamiliar users, negative for active users). This is why heterogeneity analysis is essential.
- **Positive β for unfamiliar users only**: Consistent with the discovery mechanism but could also reflect measurement: unfamiliar users have fewer alternative channels, so their purchases are more likely to be attributed to paid search even if the causal mechanism is the same.
- **Immediate effect with no growth**: More consistent with route substitution or intent capture than with gradual discovery.

---

## 17. What Cannot Be Claimed

1. **Cannot claim the causal effect of paid search *clicks* on purchases at the individual level.** The design identifies the market-level effect of *availability*, not the individual-level effect of *exposure* or *clicking*.

2. **Cannot definitively distinguish demand creation from route substitution.** Market-level aggregate sales cannot reveal whether a purchase in a treated market came via paid search or would have occurred via organic search anyway. Segment heterogeneity provides suggestive evidence but not causal proof of the mechanism.

3. **Cannot claim external validity to other firms, platforms, product categories, or time periods.** The estimate is specific to the firm, campaign, markets, and time period in the data.

4. **Cannot claim the effect of optimal or re-optimized paid search spending.** The design estimates the effect of the firm's *actual* campaign configuration, not the effect of a theoretically optimal allocation.

5. **Cannot claim long-run equilibrium effects.** Repeated exposure, learning, and competitor response may change the effect over horizons longer than the intervention window.

6. **Cannot claim that zero aggregate effect implies zero value of paid search.** Paid search may provide value through channels not measured (brand awareness, complementarity with other channels) or may have segment-specific effects that average to zero.

7. **Cannot identify general equilibrium or platform-level effects.** The design captures partial equilibrium effects for one firm in finite markets.

8. **Cannot make precise quantitative claims about effect magnitudes without standard errors that account for the small number of markets.** If the number of markets is small, confidence intervals will be wide.

---

## 18. Additional Data Needed

The following data would strengthen the design but are not assumed to be available unless the packet states otherwise:

1. **Individual-level channel-path data**: Complete user journeys (search query → click channel → purchase) to distinguish paid-search-attributed purchases from organic or direct purchases. This would enable within-market channel-substitution analysis.

2. **Other marketing activity data**: Spend and timing for email, display, social, and other campaigns by market, to control for correlated marketing changes.

3. **Search query content**: Query text or category to distinguish navigational queries (user already knows the firm) from exploratory queries (user discovering the category). This is the most direct way to separate discovery from route substitution at the query level.

4. **Competitor activity data**: Competitor paid search activity, pricing, and promotions in each market during the intervention.

5. **Geographic proximity or distance measures**: Between-market distances to model and bound spatial spillovers.

6. **Market-level demographic and economic covariates**: To check balance and include as controls if pre-trends are not perfectly parallel.

7. **Longer post-intervention panel**: To estimate persistence and decay of effects, and to distinguish short-run substitution from longer-run discovery and retention.

8. **User-level identifiers linkable across devices**: To reduce measurement error in segment classification.

9. **Details on treatment assignment rule**: Why specific markets received or did not receive paid search. If assignment was based on observable characteristics, those characteristics should be included as covariates. If assignment was essentially arbitrary (e.g., platform testing infrastructure), the design is substantially stronger.

---

## 19. Threat-Response Table

| Threat | Why It Matters | Proposed Diagnostic or Design Response | Remaining Limitation |
|---|---|---|---|
| **Individual-level intent-selection confound**: Clicked traffic and attributed conversions overstate causal value because users with high purchase intent self-select into clicking | This is the fundamental threat motivating the market-level design. Individual-level analyses would systematically overstate the causal effect | Move identification to the market level where treatment (availability) is firm-controlled, not user-selected. Estimate ITT of availability rather than treatment-on-treated of clicking | Market-level ITT is policy-relevant but cannot recover the individual-level treatment effect of ad exposure without additional assumptions (instrumental variables or experimental variation in exposure intensity) |
| **Non-parallel pre-trends**: Treated and untreated markets may differ in demand trends or seasonality | Violates the core DiD identifying assumption; post-period differences may reflect pre-existing divergence | Event-study specification with formal pre-trend tests (joint F-test on pre-period β_k). If pre-trends are parallel, this threat is mitigated | Cannot test the counterfactual parallel trend during the intervention period. Time-varying unobserved confounds during the intervention remain possible |
| **Route substitution vs. demand creation confounding**: Observed sales effects reflect channel shifting, not new demand | An aggregate positive effect may be misinterpreted as demand creation when it is only channel reallocation. Misinforms budget allocation decisions | Segment-stratified DiD: test whether effects are concentrated among low-familiarity/inactive users (consistent with discovery) rather than active users (consistent with substitution). Event-study dynamics: discovery effects may grow over time | Market-level data cannot definitively separate discovery from substitution even with segment analysis. Within-segment, both mechanisms can operate |
| **Aggregation masking heterogeneity**: Near-zero average effects hide positive effects for unfamiliar users and negative/zero effects for active users | Leads to incorrect conclusion that paid search is "ineffective" when it may be valuable for specific segments | Estimate segment-specific DiD and test for effect heterogeneity. Decompose aggregate effect into segment contributions | Requires sufficient segment cell sizes. Segments defined from pre-period data may not perfectly capture the relevant heterogeneity |
| **Cross-market or cross-channel spillovers**: Users in untreated markets may use paid search in treated markets; users in treated markets may substitute across channels | Biases the DiD comparison by affecting both treatment and control outcomes. Direction of bias depends on nature of spillover | Diagnostic: examine untreated-market sales trends for declines relative to pre-trend. If spillover is suspected, interpret DiD as a bound. Consider spatial models if market proximity data exist | Cannot fully rule out spillovers without individual-level location data or border-discontinuity designs |
| **Market-level compliance/Intensity variation**: Binary treatment masks variation in ad intensity, coverage, or effective reach across treated markets | The binary DiD estimates a weighted average that may not represent the effect of a well-executed campaign. Attenuates estimates if some "treated" markets had minimal effective exposure | If intensity data (spend, impressions, duration) are available, estimate dose-response models. Report binary DiD as ITT alongside intensity-weighted estimates | Intensity data may be endogenous (higher-spend markets may have higher baseline demand). Binary ITT remains the cleanest causal estimate |
| **Segment classification measurement error**: Incomplete user histories (cookie deletion, cross-device, unidentified users) cause segment misclassification | Attenuates segment-specific estimates toward zero and toward the aggregate effect. May mask true heterogeneity | Report the proportion of unclassified purchases. If segment data are available from a login-based or persistent-identifier system, measurement error is reduced. Use pre-period data for classification | Measurement error in the segment variable cannot be corrected without validation data or instrumental-variable approaches for misclassification |
| **Small number of clusters**: Treatment varies at the market level, so effective sample size is the number of markets, not market-time observations | Cluster-robust standard errors with few clusters are downward-biased, inflating false-positive rates | Use wild cluster bootstrap for inference. Complement with synthetic control methods (case-study inference rather than frequentist). Report p-values from randomization inference | With very few markets (e.g., < 10 per arm), even these corrections have limited power. Acknowledge imprecision |
| **Anticipatory behavior**: Users or the firm change behavior before treatment based on knowledge of upcoming campaign | Can create spurious pre-trends or bias the estimated effect if behavior adjusts before the official intervention date | Test for effects in the period immediately before treatment (β_{-1} in event study). If significant, extend the pre-period or redefine the intervention date | Cannot rule out anticipation if the campaign was pre-announced or if platform changes were visible before the formal start date |
| **Endogenous treatment assignment**: Markets were selected for paid search based on expected returns or other characteristics correlated with outcomes | Undermines the claim that treatment is exogenous at the market level. Parallel pre-trends may hold if selection is on fixed characteristics (absorbed by fixed effects) but not if selection is on expected trends | Test balance on pre-period characteristics. If assignment rule is known, include assignment variables as controls interacted with time. Use SCM to match on pre-period outcomes | If assignment was based on private managerial expectations of future demand, this is fundamentally untestable |
| **Repeated exposure and dynamic effects**: Users in treated markets face repeated search opportunities; effects may cumulate, decay, or interact over time | The static DiD captures the average effect over the intervention window but masks important dynamics | Event-study specification reveals time path of effects. Report both average and period-specific estimates | Cannot separately identify the effect of first exposure vs. cumulative exposure without variation in treatment duration across markets |

---

## 20. Claim-Evidence Table

| Claim | Evidence Used | Claim Type | Confidence | What Would Falsify This Claim |
|---|---|---|---|---|
| Paid search availability causes a change in aggregate downstream purchases of magnitude β | DiD estimate of β with market-clustered inference; pre-trend diagnostics; event-study coefficients | Causal (under parallel trends) | Moderate to high if pre-trends hold; low if pre-trends fail | Significant pre-trend coefficients; failure of in-time placebo tests; sensitivity to exclusion of any single market; significant differential shocks during intervention |
| The aggregate effect masks heterogeneous effects across user segments | Comparison of segment-specific β^s; formal test of β^new = β^active | Descriptive heterogeneity; suggestive of mechanism | Moderate if segments are well-powered; low if cell sizes are small | All segment-specific effects are statistically indistinguishable from each other |
| Effects for low-familiarity users are larger than for active users | β^low_familiarity > β^active; significant DDD interaction term | Descriptive pattern; suggestive of discovery mechanism | Moderate | Reversal (β^active > β^low_familiarity); no significant difference between segments |
| Observed effects for active users reflect route substitution rather than demand creation | Near-zero or negative β^active combined with stable aggregate organic/direct traffic shares (if observable) | Mechanism inference; not causally identified | Low (mechanism claim without channel-path data) | Positive β^active that is not explainable by increased category demand; evidence that active users increase total purchase volume rather than shifting channels |
| Paid search is not uniformly "effective" or "ineffective" | Significant heterogeneity in segment-specific effects; aggregate β near zero with opposite-signed segment effects | Descriptive summary of evidence pattern | Moderate if heterogeneity is statistically significant | Uniform effects across all segments; no detectable heterogeneity |
| The estimated effect is specific to the studied firm, markets, and time period | All estimates are conditional on the sample; no out-of-sample validation data | Descriptive (external validity limitation) | High (this is a statement about what cannot be claimed) | Replication in different settings with similar estimates would support external validity, but cannot falsify the claim that *this* estimate is sample-specific |
| Individual-level click-to-conversion metrics overstate the causal effect of paid search | Comparison of market-level DiD (ITT) with naive pre-post or click-attributed metrics (if available) | Causal if market-level estimate is valid; comparison requires both metrics | Moderate (requires both market-level and click-level data) | Market-level DiD estimate equals or exceeds individual-level attribution estimates |

---

## Summary Assessment

This design provides a defensible framework for estimating the causal effect of paid search *availability* on downstream purchases at the market level, using a difference-in-differences strategy that addresses the fundamental intent-selection problem by moving identification to the level at which treatment is assigned. The parallel-trends assumption is testable, and the panel structure supports event-study diagnostics and segment-level heterogeneity analysis.

The design's primary limitations are: (1) it identifies an ITT of availability rather than the effect of ad exposure or clicks; (2) it cannot causally separate demand creation from route substitution, though segment heterogeneity provides suggestive evidence; (3) it requires a sufficient number of markets for reliable inference; and (4) it cannot rule out spillovers or correlated marketing changes without additional data.

The strongest conclusions available are about the *existence and magnitude* of market-level effects and their *heterogeneity across user segments*, not about the precise behavioral mechanisms generating those effects.

## Tool Log Summary

- actual tool use: none
- trajectory `toolMetas`: []
- toolCall count: 0
- toolResult count: 0
- session_id: isolated_20260527_223821_98725_9
- session_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260527_223821_98725_9.jsonl
- trajectory_log: /Users/jiangcanxiang/.openclaw/agents/benchmark_isolated/sessions/isolated_20260527_223821_98725_9.trajectory.jsonl

## Operator Notes

- duration_ms: 284391
- stderr_excerpt: [plugins] plugins.allow is empty; discovered non-bundled plugins may auto-load: qqbot (/Users/jiangcanxiang/.openclaw/npm/node_modules/@openclaw/qqbot/dist/index.js), openclaw-weixin (/Users/jiangcanxiang/.openclaw/npm/node_modules/@tencent-weixin/openclaw-weixin/dist/index.js). Set plugins.allow to explicit trusted ids. [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/0-autoresearch-skill resolved=~/.orchestra/skills/0-autoresearch-skill [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/brainstorming-research-ideas resolved=~/.orchestra/skills/21-research-ideation/brainstorming-research-ideas [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed root=~/.openclaw/skills reason=symlink-escape requested=~/.openclaw/skills/creative-thinking-for-research resolved=~/.orchestra/skills/21-research-ideation/creative-thinking-for-research [skills] Skipping escaped skill path outside its configured root: source=openclaw-managed r
